Itaconix PLC
20 August 2026
For release: 07:00, 20 August 2026
Itaconix plc
("Itaconix" or the "Company")
Notice of Results and Company Presentation
Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in high-performance plant-based specialty polymers used in everyday consumer products, announces that its Interim Results for the period ended 30 June 2026 will be released on 8 September 2026.
Investor Meet Company presentation
A live presentation will be held on 9 September 2026 at 14:00 BST. This presentation is open to all interested parties. Anyone can sign up for free to the Investor Meet Company platform and join the live presentation via:
https://www.investormeetcompany.com/itaconix-plc/register-investor
Questions can be submitted pre-event via your Investor Meet Company dashboard up until 8 September 2026, 09:00 BST, or at any time during the live presentation.
- Ends -
|
Itaconix plc John R. Shaw / Laura Denner |
+1 603 775-4400 |
|
Rosewood John West / Llewellyn Angus / Lily Pearce |
+44 (0)20 7653 8702 |
|
Canaccord Genuity - Nominated Adviser and Sole Broker Adam James / Harry Pardoe |
+44 (0) 20 7523 8000 |
About Itaconix
Itaconix plc produces and sells plant-based specialty ingredients that improve the safety, performance and environmental profile of everyday consumer and industrial products. The Company's proprietary polymer technology platform is enabling new generations of products in home care, hygiene, and emerging areas in paints and agriculture.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.